Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set ... Piero Cingari IQVIA Delivers Solid Q4 Growth ...

Howard Brown Health, the Midwest's leading health center dedicated to inclusive care, announced the appointment of Dr. Travis Gayles, MD, PhD as its new Chief Executive Officer. Dr. Gayles brings a ...

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

The Institute for Women's Policy Research (IWPR) proudly launched its first-ever Federal Policy Solutions to Advance Gender Equity agenda today. This bold blueprint presents actionable recommendations ...

IQVIA to create northern 'Prime Site' for R&D ... pledging to invest £2 million in a new facility, creating 20 jobs. In a further development, the government’s Strategic Priorities Fund will ...

DeepSeek massively disrupted the artificial intelligence story. All after DeepSeek “presented a ChatGPT-like model called R1, ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...